LCM
KRON

Laurion Capital Management’s Kronos Bio KRON Stock Holding History

Laurion Capital Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$293K – 830
2021
Q1 		$293K Hold
10,000
– – ﹤0.01% 654
2020
Q4 		$299K Buy
+10,000
New +$314K ﹤0.01% 545

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurion Capital Management's KRON Position: Q2 2021 in Review

Laurion Capital Management sold out of Kronos Bio (KRON) in Q2 2021, closing a stake of 10,000 shares — an estimated $293K sold.

Laurion Capital Management first reported a position in KRON in Q4 2020 and held it in 2 quarters. The position peaked at $299K in Q4 2020. 77 funds tracked by Wall St. Rank hold KRON as of Q2 2021.

  • Laurion Capital Management reported no remaining Kronos Bio position as of Q2 2021 after selling out during the quarter.
  • Laurion Capital Management sold 10,000 Kronos Bio shares in Q2 2021, an estimated $293K.
  • Laurion Capital Management first reported a position in Kronos Bio in Q4 2020 and held it in 2 quarters.
  • Laurion Capital Management's Kronos Bio position peaked at $299K in Q4 2020.
  • 77 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2021.

Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.